相关实验视频

Updated: May 30, 2025

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

慢性移植对宿主性脊髓炎成功地用Rituximab治疗

Emi Yokoyama¹, Yuta Hasegawa², Kentaro Wakaki³

¹Blood Disorders Center, Aiiku Hospital, S4W25, Chuo-ku, Sapporo, 064-0804, Japan. chatte_brillante@yahoo.co.jp.

International journal of hematology

|January 31, 2025

概括

慢性移植对宿主疾病 (cGVHD) 可以影响中枢神经系统 (CNS),模仿自身免疫性疾病. 利图西马布有效地治疗了对类固醇耐药的中枢神经系统cGVHD髓炎,这表明重新定位的自身免疫治疗方法.

科学领域:

血液学血液学血液学
神经学神经学
免疫学免疫学免疫学

背景情况:

慢性移植与宿主疾病 (cGVHD) 是异构干细胞移植 (allo-HSCT) 后的一个重大并发症.
中枢神经系统 (CNS) 在cGVHD中的参与是罕见的,具有挑战性的诊断,并被认为是一种非典型的表现.
中枢神经系统cGVHD可以呈现出模仿自身免疫神经系统疾病的症状.

研究的目的:

报告中枢神经系统 (中枢神经系统) 慢性移植对宿主疾病 (cGVHD) 的病例,呈现为骨髓炎.
评估Rituximab在患有耐火性中枢神经系统cGVHD的患者中的疗效.

主要方法:

一名患有骨髓炎后allo-HSCT诊断出中枢神经系统cGVHD的患者接受了治疗.
最初的治疗包括皮质类固醇脉冲疗法,这被证明是无效的.
瑞图西马布因对皮质类固醇的折射性及其在多发性硬化症中已知的有效性而被管理.

主要成果:

患者出现了渐进的神经症状,包括严重的和麻醉.
磁共振成像发现显示了与多发性硬化症的相似之处.
利图西马布治疗导致神经症状的改善.

结论:

中枢神经系统 (CNS) 慢性移植对主体疾病 (cGVHD) 可以异常表现为骨髓炎.
利图西马布在治疗对皮质类固醇耐药的中枢神经系统cGVHD髓炎方面表现出有效性.
用于类似的自身免疫性疾病的治疗方法可能对非典型的cGVHD表现有效.

关键词:

全基因干细胞移植移植.非典型的慢性移植对宿主病.中枢神经系统中枢神经系统骨髓炎是一种神经炎症.里图西马布 (Rituximab) 是一种药物.

更多相关视频

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...